NO902132L - Blandinger og fremgangsmaater for administrering av terapeutisk aktive forbindelser. - Google Patents
Blandinger og fremgangsmaater for administrering av terapeutisk aktive forbindelser.Info
- Publication number
- NO902132L NO902132L NO90902132A NO902132A NO902132L NO 902132 L NO902132 L NO 902132L NO 90902132 A NO90902132 A NO 90902132A NO 902132 A NO902132 A NO 902132A NO 902132 L NO902132 L NO 902132L
- Authority
- NO
- Norway
- Prior art keywords
- organic anions
- administration
- procedures
- mixtures
- therapeutic active
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 4
- 230000001225 therapeutic effect Effects 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 title 1
- 150000002891 organic anions Chemical class 0.000 abstract 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Natural products OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 abstract 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 abstract 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-M L-ascorbate Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-] CIWBSHSKHKDKBQ-JLAZNSOCSA-M 0.000 abstract 2
- 229930003268 Vitamin C Natural products 0.000 abstract 2
- 235000019154 vitamin C Nutrition 0.000 abstract 2
- 239000011718 vitamin C Substances 0.000 abstract 2
- QXKAIJAYHKCRRA-PZGQECOJSA-N L-lyxonic acid Chemical class OC[C@H](O)[C@@H](O)[C@@H](O)C(O)=O QXKAIJAYHKCRRA-PZGQECOJSA-N 0.000 abstract 1
- 238000010521 absorption reaction Methods 0.000 abstract 1
- 230000029142 excretion Effects 0.000 abstract 1
- 231100000252 nontoxic Toxicity 0.000 abstract 1
- 230000003000 nontoxic effect Effects 0.000 abstract 1
- 230000037361 pathway Effects 0.000 abstract 1
- 230000007756 renal tubular secretion Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Nutrition Science (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Steroid Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NO19944971A NO311219B1 (no) | 1988-09-19 | 1994-12-21 | Fremgangsmåte for fremstilling av et preparat med forbedret vitamin C-aktivitet |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US07/246,504 US4968716A (en) | 1987-04-10 | 1988-09-19 | Compositions and methods for administering therapeutically active compounds |
| PCT/US1989/001642 WO1990012571A1 (en) | 1989-04-07 | 1989-04-07 | Compositions and methods for administering vitamin c |
| PCT/US1989/004046 WO1990003167A1 (en) | 1988-09-19 | 1989-09-15 | Compositions and methods for administering therapeutically active compounds |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| NO902132D0 NO902132D0 (no) | 1990-05-14 |
| NO902132L true NO902132L (no) | 1990-05-14 |
| NO178056B NO178056B (no) | 1995-10-09 |
| NO178056C NO178056C (no) | 1996-01-17 |
Family
ID=22930954
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO902132A NO178056C (no) | 1988-09-19 | 1990-05-14 | Fremgangsmåte ved fremstilling av et farmasöytisk preparat med forbedret absorpsjon, toleranse og/eller retensjonshastighet |
Country Status (16)
| Country | Link |
|---|---|
| EP (1) | EP0417209B1 (no) |
| JP (1) | JP2973365B2 (no) |
| AT (1) | ATE160939T1 (no) |
| CA (1) | CA1341434C (no) |
| DE (1) | DE68928488T2 (no) |
| DK (1) | DK175783B1 (no) |
| FI (1) | FI97950C (no) |
| HU (1) | HU905911D0 (no) |
| NO (1) | NO178056C (no) |
| NZ (1) | NZ230700A (no) |
| PL (1) | PL165416B1 (no) |
| RO (1) | RO108148B1 (no) |
| RU (1) | RU2059410C1 (no) |
| WO (1) | WO1990003167A1 (no) |
| YU (1) | YU47746B (no) |
| ZA (1) | ZA904494B (no) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1124550B9 (en) * | 1999-08-30 | 2008-11-05 | The Ester C Company | Uses and compositions for selective cancer chemotherapy |
| JP4162593B2 (ja) * | 2001-08-24 | 2008-10-08 | ラート・マティアス | 新規アスコルビン酸化合物、その合成方法及びその使用方法 |
| AT501682A1 (de) | 2005-01-14 | 2006-10-15 | Hermine Dr Engl | Verfahren zur herstellung einer wirkstoffmischung |
| FI20095278A0 (fi) | 2009-03-18 | 2009-03-18 | Valtion Teknillinen | Ksylonihapon valmistus |
| KR101037125B1 (ko) * | 2009-05-14 | 2011-05-26 | 계명대학교 산학협력단 | 바이오에탄올 생산을 위한 바이오매스 전처리법 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2606903A (en) * | 1944-03-29 | 1952-08-12 | Physiological Chemicals Compan | Ascorbic acid addition compound of sulfathiazole |
| US2822317A (en) * | 1955-12-12 | 1958-02-04 | Smith Kline French Lab | Aqueous iron-ascorbic acid preparation |
| GB2040164A (en) * | 1979-01-31 | 1980-08-28 | Beecham Group Ltd | Compositions containing paracetamol |
| US4822816A (en) * | 1987-04-10 | 1989-04-18 | Oxycal Laboratories, Inc. | Compositions and methods for administering vitamin C |
-
1989
- 1989-09-15 WO PCT/US1989/004046 patent/WO1990003167A1/en not_active Ceased
- 1989-09-15 RO RO145105A patent/RO108148B1/ro unknown
- 1989-09-15 DE DE68928488T patent/DE68928488T2/de not_active Expired - Lifetime
- 1989-09-15 JP JP1510161A patent/JP2973365B2/ja not_active Expired - Lifetime
- 1989-09-15 AT AT89910989T patent/ATE160939T1/de not_active IP Right Cessation
- 1989-09-15 RU SU4830452/14A patent/RU2059410C1/ru active
- 1989-09-15 EP EP89910989A patent/EP0417209B1/en not_active Expired - Lifetime
- 1989-09-18 CA CA000611779A patent/CA1341434C/en not_active Expired - Lifetime
- 1989-09-19 NZ NZ230700A patent/NZ230700A/en unknown
-
1990
- 1990-05-14 NO NO902132A patent/NO178056C/no not_active IP Right Cessation
- 1990-05-18 FI FI902461A patent/FI97950C/fi active IP Right Grant
- 1990-05-18 DK DK199001242A patent/DK175783B1/da not_active IP Right Cessation
- 1990-06-11 ZA ZA904494A patent/ZA904494B/xx unknown
- 1990-06-15 YU YU117890A patent/YU47746B/sh unknown
- 1990-09-14 HU HU905911A patent/HU905911D0/hu unknown
- 1990-09-14 PL PL90286897A patent/PL165416B1/pl unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NO902132D0 (no) | 1990-05-14 |
| FI902461A0 (fi) | 1990-05-18 |
| EP0417209A4 (en) | 1992-01-08 |
| AU4328889A (en) | 1990-04-18 |
| AU621672B2 (en) | 1992-03-19 |
| FI97950C (fi) | 1997-03-25 |
| PL165416B1 (pl) | 1994-12-30 |
| RU2059410C1 (ru) | 1996-05-10 |
| EP0417209B1 (en) | 1997-12-10 |
| HU905911D0 (en) | 1991-03-28 |
| YU47746B (sh) | 1996-01-08 |
| EP0417209A1 (en) | 1991-03-20 |
| JP2973365B2 (ja) | 1999-11-08 |
| DE68928488T2 (de) | 1998-04-02 |
| RO108148B1 (ro) | 1994-02-28 |
| NO178056B (no) | 1995-10-09 |
| ATE160939T1 (de) | 1997-12-15 |
| FI97950B (fi) | 1996-12-13 |
| DK175783B1 (da) | 2005-02-21 |
| ZA904494B (en) | 1991-03-27 |
| DK124290D0 (da) | 1990-05-18 |
| WO1990003167A1 (en) | 1990-04-05 |
| DE68928488D1 (de) | 1998-01-22 |
| NO178056C (no) | 1996-01-17 |
| NZ230700A (en) | 1992-07-28 |
| DK124290A (da) | 1990-05-18 |
| JPH03504502A (ja) | 1991-10-03 |
| CA1341434C (en) | 2003-07-08 |
| YU117890A (sh) | 1993-10-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ID24901A (id) | Metode pengobatan keadaan terkoagulasi tinggi atau defisiensi protein c yang diperoleh | |
| FI875308A0 (fi) | Foerfarande i tvao steg foer att hela ett saor smaertfritt och ett vattenhaltigt medium och en salva foer lokal anvaendning vid foerfarandet. | |
| SE8106404L (sv) | Penicillinderivat | |
| RU93032613A (ru) | Фармацевтический препарат для лечения пациентов с пролонгированным временем коагуляции, способ лечения пациентов, применение epi ингибитора для получения фармацевтического препарата | |
| DK0668077T3 (da) | Produkter, som indeholder G-CSF og TNF-bindende protein | |
| AU8091787A (en) | The use of paroxetine to treat pain | |
| NO893270L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive tetrahydropyridineddiksyrederivater. | |
| SU1337098A1 (ru) | Способ лечени звенной болезни двенадцатиперстной кишки | |
| MY104006A (en) | 4-quinoline carboxylic acid derivatives useful for treating skin and muco-epithelial diseases. | |
| IE890580L (en) | Therapeutic agent for the prevention of intraventricular hemorrhage in premature infants | |
| NO902132L (no) | Blandinger og fremgangsmaater for administrering av terapeutisk aktive forbindelser. | |
| NO893256L (no) | Fremgangsmaate for fremstilling av furyltiazolderivater. | |
| CA1215323A (en) | Curative composition for buerger's disease | |
| ATE184489T1 (de) | Behandlung fehlender milchabsonderung beim menschen | |
| Hoskins | The Relation of the Adrenals to the Circulation | |
| DE3650368D1 (de) | Verwendung von Depogen zur Behandlung von eingeschränktem Blutkreislauf. | |
| NO168825C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 3-pyrrolidinyltio-1-azabicyklo (3.2.0) hept-2-en-2-karboksylsyrederivater | |
| JPS643123A (en) | Remedy for skin inflammation | |
| KR890001555A (ko) | 요산 배설용 조성물 | |
| Engeset et al. | Clostridium welchii infection: an unusual case | |
| Hoskins | As to the cause of collapse following adrenal extirpation, Elliott (9) | |
| RU98111356A (ru) | Способ лечения ожогового шока | |
| RU92016264A (ru) | Новые соединения, способ их получения, фармацевтический состав, его получение, способ профилактики или лечения, применение соединений | |
| RU96117516A (ru) | Способ лечения пре- и пролиферативной диабетической ретинопатии |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK1K | Patent expired |